Choosing Wisely
ASNC Announces the 2019
Nuclear Cardiology Choosing Wisely® Challenge
Finalists
Multi-pronged approach to optimize nuclear cardiology testing and improve safety
at Kaiser Permanente, Mid-Atlantic states (Virginia, Maryland, Washington, D.C.)
at Kaiser Permanente, Mid-Atlantic states (Virginia, Maryland, Washington, D.C.)
Sudip Saha, MD; Joseph Lodato, MD; Nancy Ortiz, MPH, CPHQ, PMP
Mid Atlantic Permanente Medical Group
Development of a patient centered, cost effective algorithm utilizing 99mTechnetium-Pyrophosphate
imaging to diagnose ATTR cardiac amyloidosis
imaging to diagnose ATTR cardiac amyloidosis
Benita Philip, DO; Barbara Schechter, DO; Denise Kale, CNMT;
Renee P. Bullock-Palmer, MD, FASNC
Renee P. Bullock-Palmer, MD, FASNC
Department of Cardiology, Deborah Heart and Lung Center
Impact of a novel myocardial perfusion imaging risk classification scheme on referral
for coronary angiography, revascularization, and mortality
for coronary angiography, revascularization, and mortality
Anirudh Kumar, MD; Paul Cremer, MD; Rory Hachamovitch, MD, FASNC; Wael Jaber, MD
Cleveland Clinic Foundation
AWARD
ASNC will award three prizes based on the most innovative, creative ideas and implementable plans:
1st Prize - $3,000
2nd Prize - $2,500
3rd Prize - $1,000
The three finalists will be invited to present their solutions to a live viewing audience and an evaluation panel at ASNC2019 in Chicago, Ill. All parties submitting agree to pay their own expenses to ASNC19 and underwrite any related presentation materials, should their submission be selected for presentation.
ASNC will promote the finalists in the ASNC2019 Final Program, in the Journal of Nuclear Cardiology, in media releases, and in ASNC member communications including ASNC’s social media channels.
Participants may be asked at a later date to provide a brief summary and/or video describing their solution, which will be posted publicly on ASNC’s Nuclear Cardiology Choosing Wisely® Challenge portal.
.png){kind=spacer}
Thanks to our sponsor Bracco Diagnostics Inc.Phase 2 - Live Evaluation
- The live evaluation panel may include some or all members of the Phase 1 Evaluation Panel, as well as additional qualified individuals from various medical and non-medical backgrounds.
- After the three finalists’ presentations at ASNC2019, the finalists will be ranked by a combination of votes by the live evaluation panel and the audience.
Evaluation Panel decisions and winner are final, binding, and shall not be subject to appeal or change.
STAFF CONTACT
Alison Bondurant
abondurant@asnc.org
703-459-2555 ext. 2553
Thanks to those that took the 2018 challenge!
Winning submissions support ASNC’s goal of encouraging the right test for the right patient at the right time and were presented at ASNC2018.
Feasibility & Initial Results of a Decision to Test Algorithm Using DASI in Operable Lung Cancer Patients - Christopher Johnson, MD, Nadine Gauthier, MD, FRCP; Angeline Law, MD, FRCP; Eugene Leung, MD, FRCP; Calvin Thompson, MD, FRCP
Point-of-Order Consultation Reduces Rarely Appropriate Testing and Allows for Test-Independent Cardiovascular Risk Reduction - Nishant Shah, MD, PhD; Wen-Chih (Hank) Wu, MD, MPH; Hafiz Imran; Aaron Eisman; Indra Neil Sarkar, PhD, MLIS; David Winchester, MD
Systematic Cardiac Risk Assessment with PET/CT Myocardial Perfusion Imaging using an Objective Risk Score Approach - David Min, MD;Steve Mason, PA-C; Jon-David Ethington, PA-C; Raymond McCubrey, MStat; Kent Meredith, MD
Systematic Cardiac Risk Assessment with PET/CT Myocardial Perfusion Imaging using an Objective Risk Score Approach - David Min, MD;Steve Mason, PA-C; Jon-David Ethington, PA-C; Raymond McCubrey, MStat; Kent Meredith, MD